Company intelligence / Profile preview

Quan Venture Fund

Shanghai, Shanghai Municipality, China

Ownership: Private
Employees: ~3
Development stage: Other

Overview

Quan Capital is a leading healthcare VC firm, active globally and in China, investing in innovative early and growth-stage therapeutics, diagnostics, and enabling technologies. Its portfolio includes companies with clinical assets spanning preclinical to early commercial stages, focusing on breakthrough modalities and targets.

Therapeutic areas: OncologyRare DiseasesImmunology
Modalities: Antibody-drug conjugateProteinSmall moleculeBiologic
Industry: Investors

Partnerships

OrbiMedQiming Venture PartnersTakeda Ventures

Beyond the preview

Go deeper on Quan Venture Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quan Venture Fund.

Explore the full profile